An Internist’s Update on Cholesterol Management

American Heart Association, 1998 Manninen, 1988, Lipid alterations decline in the incidence of coronary heart disease in the Helsinki Heart Study, JAMA, 260, 641, 10.1001/jama.1988.03410050061031 Anonymous, 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383 Sacks, 1996, The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol Recurrent Events Trial investigators, N Engl J Med, 335, 1001, 10.1056/NEJM199610033351401 Anonymous, 1998, Prevention of cardiovascular events death with pravastatin in patients with coronary heart disease a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group, N Engl J Med, 339, 1349, 10.1056/NEJM199811053391902 Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group, N Engl J Med, 333, 1301, 10.1056/NEJM199511163332001 Anonymous, 1988, Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults. The Expert Panel, Arch Intern Med, 148, 36, 10.1001/archinte.1988.00380010040006 Anonymous, 1994, National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II), Circulation, 89, 1333, 10.1161/01.CIR.89.3.1333 2001 1995 Brown, 1986, A receptor mediated pathway for cholesterol homeostasis, Science, 232, 34, 10.1126/science.3513311 Goldstein, 1973, Hyperlipidemia in coronary heart disease.II Genetic analysis of lipid levels in 176 families delineation of a new inherited disorder, combined hyperlipidemia, J Clin Invest, 52, 1544, 10.1172/JCI107332 Hobbs, 1999, ABC1: connecting yellow tonsils, neuropathy, very low HDL, J Clin Invest, 104, 1015, 10.1172/JCI8509 Stone, 2000 Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study, Am J Med, 62, 707, 10.1016/0002-9343(77)90874-9 Downs, 1998, Primary prevention of acute coronary events with lovastatin in men women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study, JAMA, 279, 1615, 10.1001/jama.279.20.1615 Rubins, 1999, Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group, N Engl J Med, 341, 410, 10.1056/NEJM199908053410604 Hulley, 1998, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart Estrogen/progestin Replacement Study (HERS) Research Group, JAMA, 280, 605, 10.1001/jama.280.7.605 NHLBI Obesity Education Initiative. Available at: URL: http://www.nhlbi.nih.gov/about/oei/ Carlson, 1989, Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid, J Intern Med, 226, 271, 10.1111/j.1365-2796.1989.tb01393.x